Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; The EnvIMS Study

Multiple Sclerosis Journal

Volumn 20, Issue 6, 2014, Pages 669-674

  Lossius, Andreas ^a,b   Riise, Trond ^c   Pugliatti, Maura ^c,d   Bjørnevik, Kjetil ^c   Casetta, Ilaria ^e   Drulovic, Jelena ^f   Granieri, Enrico ^e   Kampman, Margitta T ^g,h   Landtblom, Anne Marie ⁱ   Lauer, Klaus ^j   Magalhaes, Sandra ^k   Myhr, Kjell Morten ^c,l   Pekmezovic, Tatjana ^f   Wesnes, Kristin ^c   Wolfson, Christina ^k,m   Holmøy, Trygve ^a,n  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITY OF SASSARI   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

^f UNIVERSITY OF BELGRADE   (Serbia)

^g UNIVERSITY OF TROMSØ   (Norway)

^h UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

ⁱ LINKÖPING UNIVERSITY   (Sweden)

^j Department of Epidemiology and Biostatistics and Occupational Health McGill University ^*

^k MCGILL UNIVERSITY   (Canada)

^l HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^m RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

ⁿ AKERSHUS UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

Epstein Barr virus; interaction; latitude; Multiple sclerosis; seasons; vitamin D

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FALLING; FEMALE; HUMAN; ITALY; LATITUDE; MAJOR CLINICAL STUDY; MALE; MONONUCLEOSIS; MULTIPLE SCLEROSIS; NORWAY; ONSET AGE; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; SELF REPORT; SPRING; SUMMER; WINTER; AUTUMN; ENVIRONMENTAL FACTOR; SOLAR RADIATION; AGED; CLINICAL TRIAL; COMPLICATION; CONTROLLED CLINICAL TRIAL; EPSTEIN BARR VIRUS INFECTION; INFECTIOUS MONONUCLEOSIS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RISK; SEASON; VIROLOGY;

VITAMIN D;

ADULT; AGED; CASE-CONTROL STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; INFECTIOUS MONONUCLEOSIS; ITALY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NORWAY; RISK; SEASONS; VITAMIN D;

EID: 84899054811     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513505693     Document Type: Article

References (37)

1. Simpson S, Blizzard L, Otahal P, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J Neurol Neurosurg Psychiatry. 2011 ; 82: 1132-1141
2. Cabre P. Migration and multiple sclerosis: The French West Indies experience. J Neurol Sci. 2007 ; 262: 117-121
3. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010 ; 9: 520-532
4. Warner HB, Carp RI. Multiple sclerosis and Epstein-Barr virus. Lancet. 1981 1290 ; 2 :
5. Haahr S, Koch-Henriksen N, Moller-Larsen A, et al. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: A historical prospective study. Mult Scler. 1995 ; 1: 73-77
6. Nielsen TR, Rostgaard K, Nielsen NM, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol. 2007 ; 64: 72-75
7. Ramagopalan SV, Valdar W, Dyment DA, et al. Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology. 2009 ; 32: 257-262
8. Handel AE, Williamson AJ, Disanto G, et al. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One. 2010 ;:
9. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 2007 ; 61: 504-513
10. Holmoy T. Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis. Med Hypotheses. 2008 ; 70: 66-69
11. Salzer J, Nystrom M, Hallmans G, et al. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples. Mult Scler. :
12. Ramagopalan SV, Handel AE, Giovannoni G, et al. Relationship of UV exposure to prevalence of multiple sclerosis in England. Neurology. 2011 ; 76: 1410-1414
13. Jorde R, Sneve M, Hutchinson M, et al. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol. 2010 ; 171: 903-908
14. Christensen MH, Lien EA, Hustad S, et al. Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway. Scand J Clin Lab Invest. 2010 ; 70: 281-286
15. Carnevale V, Nieddu L, Romagnoli E, et al. Regulation of PTH secretion by 25-hydroxyvitamin D and ionized calcium depends on vitamin D status: A study in a large cohort of healthy subjects. Bone. 2010 ; 47: 626-630
16. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol. 2005 ; 58: 840-846
17. Midgard R. Incidence and prevalence of multiple sclerosis in Norway. Acta Neurol Scand Suppl. 2012: 36-42
18. Myhr KM, Grytten N, Aarseth JH. The Norwegian Multiple Sclerosis Registry and Biobank. Acta Neurol Scand Suppl. 2012: 20-23
19. Granieri E, Economou NT, De Gennaro R, et al. Multiple sclerosis in the province of Ferrara: Evidence for an increasing trend. J Neurol. 2007 ; 254: 1642-1648
20. Granieri E, Casetta I, Govoni V, et al. The increasing incidence and prevalence of MS in a Sardinian province. Neurology. 2000 ; 55: 842-848
21. Pugliatti M, Casetta I, Drulovic J, et al. A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q). Acta Neurol Scand Suppl. 2012: 43-50
22. Van Belle TL, Gysemans C, Mathieu C. Vitamin D in autoimmune, infectious and allergic diseases: A vital player?. Best Pract Res Clin Endocrinol Metab. 2011 ; 25: 617-632
23. Engelsen O, Brustad M, Aksnes, et al. Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol. 2005 ; 81: 1287-1290
24. Fisman D. Seasonality of viral infections: Mechanisms and unknowns. Clin Microbiol Infect. 2012 ; 18: 946-954
25. Zwart SR, Mehta SK, Ploutz-Snyder R, et al. Response to vitamin D supplementation during Antarctic winter is related to BMI, and supplementation can mitigate Epstein-Barr Virus Reactivation. J Nutr. 2011 ; 141: 692-697
26. Hobson FG, Lawson B, Wigfield M. Glandular fever: A field study. Br Med J. 1958 ; 1: 845-852
27. Dunnet WN. Infectious Mononucleosis. Br Med J. 1963 ; 1: 1187-1191
28. Heath CW, Brodsky AL, Potolsky AI. Infectious mononucleosis in a general population. Am J Epidemiol. 1972 ; 95: 46-52
29. Belfrage S. Infectious mononucleosis. An epidemiological and clinical study. Acta Med Scand. 1962 ; 171: 531-541
30. Brodsky AL, Heath CW. Infectious mononucleosis: Epidemiologic patterns at United States colleges and universities. Am J Epidemiol. 1972 ; 96: 87-93
31. Douglas AS, Brown T, Reid D. Infectious mononucleosis and Hodgkin's disease-a similar seasonality. Leuk Lymphoma. 1996 ; 23: 323-331
32. Balfour HH, Odumade OA, Schmeling DO, et al. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis. 2013 ; 207: 80-88
33. Levine H, Mimouni D, Grotto I, et al. Secular and seasonal trends of infectious mononucleosis among young adults in Israel: 1978-2009. Eur J Clin Microbiol Infect Dis. 2012 ; 31: 757-760
34. Munger KL, Levin LI, O'Reilly EJ, et al. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: A prospective study among United States military personnel. Mult Scler. 2011 ; 17: 1185-1193
35. Nielsen TR, Rostgaard K, Askling J, et al. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult Scler. 2009 ; 15: 431-436
36. Sundqvist E, Sundstrom P, Linden M, et al. Epstein-Barr virus and multiple sclerosis: Interaction with HLA. Genes Immun. 2012 ; 13: 14-20
37. Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med. 2007 ; 120 911: e1 - e8